Viatris Innovation Gmbh
Clinical trials sponsored by Viatris Innovation Gmbh, explained in plain language.
A German subsidiary of Viatris, a global healthcare company making generic and branded medicines.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New hope for lupus patients: drug trial targets kidney damage
Disease control Recruiting nowThis study tests if a new drug called cenerimod can help people with lupus who have active kidney disease (lupus nephritis). About 300 adults will take either cenerimod or a placebo daily for 76 weeks, on top of their usual treatments. The main goal is to see if cenerimod improve…
Phase: PHASE3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New blood thinner tested in small chinese heart study
Knowledge-focused Recruiting nowThis early-stage trial will study how a single 16 mg dose of selatogrel, an injectable blood thinner, is absorbed and tolerated in 20 Chinese adults with chronic coronary syndrome. Participants will stay at a clinic for a few days and receive either selatogrel or a placebo. The g…
Phase: PHASE1 • Sponsor: Viatris Innovation GmbH • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC